What's the deal with "Auvelity"? (new NMDA receptor antagonist)

Got a notification that some biotech stock shot up about 35% today. Turns out that company just got FDA approval for "auvelity" and is marketing it as the greatest thing to come out for depression treatment since SSRIs. Looking into it the chemical formulation seems to be "dextromethorphan HBr -bupropion HCl", and it has been challenging finding peer reviewed articles about how well it really works. Perhaps I'm just too dumb to understand the pharmacology behind it, but isn't this... Read more
Source: Student Doctor Network - Category: Universities & Medical Training Authors: Tags: Psychiatry Source Type: forums